Selexis is a privately held biotechnology company. Selexis SA has no securities registered under the United States Securities Act of 1933. Materials contained on this site do not constitute a solicitation, offer or recommendation concerning, or refer in any way to, any sale of securities.
Investors
Selexis SA is a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins.
© 2012 Selexis SA. All rights reserved.